Drug:
Reaction: DYSPNOEA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26561361 |
US |
1 | |
Dyspnoea, Chest discomfort, |
||||
SPARSENTAN, |
||||
| 102 | 26561501 |
CA |
1 | |
Dyspnoea, Cardiac failure congestive, Pneumonia, |
||||
ECULIZUMAB, ECULIZUMAB, |
||||
| 103 | 26561615 |
CA |
65 | 2 |
Pneumonia, Drug hypersensitivity, Vomiting, Wheezing, Dyspnoea, Asthma, Oedema, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, OMALIZUMAB, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, FLUTICASONE PROPIONATE, |
||||
| 104 | 26561616 |
US |
2 | |
Dyspnoea, Fatigue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, EZETIMIBE, ACETAMINOPHEN, PRAVASTATIN SODIUM, OLMESARTAN MEDOXOMIL, OXYGEN, 0XYGEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FERROUS SULFATE, |
||||
| 105 | 26565977 |
73 | 1 | |
Oxygen saturation decreased, Dyspnoea, Chest discomfort, Dizziness, Dysphonia, |
||||
OMALIZUMAB, |
||||
| 106 | 26566431 |
1 | ||
Dyspnoea, |
||||
MOMELOTINIB, |
||||
| 107 | 26570023 |
71 | 1 | |
Dyspnoea, Hypoxia, Chest discomfort, Pneumonia, Pneumonitis, Cardiac failure congestive, Acute respiratory failure, |
||||
CARBOPLATIN, |
||||
| 108 | 26570210 |
48 | 2 | |
Swollen tongue, Pharyngeal swelling, Dyspnoea, Throat tightness, |
||||
LISINOPRIL, |
||||
| 109 | 26570213 |
32 | 2 | |
Musculoskeletal stiffness, Paraesthesia, Hypoaesthesia, Agitation, Clumsiness, Headache, Somnolence, Dyspnoea, Heart rate increased, Palpitations, Memory impairment, |
||||
VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 110 | 26570286 |
38 | 1 | |
Chest pain, Dyspnoea, Palpitations, Hypokalaemia, Fibrin D dimer increased, Neuralgia, Chest pain, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 111 | 26550037 |
US |
2 | |
Post-traumatic stress disorder, Cough, Wheezing, Dyspnoea, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, PRAVASTATIN SODIUM, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, MAGNESIUM, KETOTIFEN FUMARATE, EZETIMIBE, |
||||
| 112 | 26550055 |
JP |
1 | |
Pulmonary toxicity, Pleural effusion, Dyspnoea, Cough, Haemoptysis, Oxygen saturation decreased, |
||||
BELZUTIFAN, BELZUTIFAN, |
||||
| 113 | 26550139 |
US |
2 | |
Dyspnoea, Ageusia, Anosmia, Product dose omission issue, Road traffic accident, |
||||
DUPILUMAB, LORAZEPAM, MONTELUKAST SODIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, CETIRIZINE HYDROCHLORIDE, |
||||
| 114 | 26550267 |
|||
Heart rate increased, Angina pectoris, Dyspnoea, Drug ineffective, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RIVAROXABAN, |
||||
| 115 | 26550287 |
US |
2 | |
Pneumonia, Chest discomfort, Dyspnoea, Wheezing, Cough, Loss of personal independence in daily activities, Exercise tolerance decreased, Asthma, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 116 | 26550301 |
US |
2 | |
Pneumonitis, Eosinophil count increased, Cough, Dyspnoea, Muscle spasms, Drug effective for unapproved indication, Off label use, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, ALBENDAZOLE, ALBENDAZOLE, PRAZIQUANTEL, |
||||
| 117 | 26550317 |
US |
2 | |
Dyspnoea, Unevaluable event, |
||||
DAPAGLIFLOZIN, |
||||
| 118 | 26550421 |
US |
48 | 2 |
Dyspnoea, Abdominal pain upper, Fatigue, Nausea, Diarrhoea, |
||||
ABEMACICLIB, |
||||
| 119 | 26550628 |
CA |
16 | 1 |
Acute respiratory distress syndrome, Empyema, Mycoplasma infection, Pleural effusion, Infectious pleural effusion, Atelectasis, Dyspnoea, Lung opacity, Nasal flaring, Tachypnoea, Use of accessory respiratory muscles, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFAZOLIN SODIUM, CEFAZOLIN, MICAFUNGIN SODIUM, MICAFUNGIN SODIUM, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VORICONAZOLE, VORICONAZOLE, METHYLPREDNISOLONE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, RITUXIMAB, |
||||
| 120 | 26550660 |
US |
||
Dyspnoea, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 121 | 26550677 |
US |
2 | |
Dyspnoea, Anger, Device delivery system issue, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 122 | 26550684 |
US |
82 | 1 |
Dyspnoea, |
||||
MARIBAVIR, |
||||
| 123 | 26550705 |
IN |
32 | 2 |
Dyspnoea, Intentional overdose, Haemodynamic instability, Reperfusion injury, Peripheral ischaemia, Compartment syndrome, |
||||
AMLODIPINE, |
||||
| 124 | 26550866 |
US |
47 | 2 |
Tachycardia, Dyspnoea, Incorrect dose administered, |
||||
TIRZEPATIDE, |
||||
| 125 | 26550884 |
EU |
86 | 2 |
COVID-19, Atrial fibrillation, Vomiting, Nausea, Asthenia, Dyspnoea, |
||||
CARFILZOMIB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, BIMATOPROST, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LEUCOVORIN CALCIUM, ENOXAPARIN SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 126 | 26550889 |
EU |
59 | 2 |
Visual impairment, Flushing, Nausea, Heart rate increased, Dyspnoea, Hypotension, |
||||
PEMBROLIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 127 | 26550955 |
EU |
81 | 2 |
Bradycardia, Wound haemorrhage, Dizziness, Dyspnoea, Haematoma, Off label use, Medication error, Therapeutic product effect decreased, |
||||
AMLODIPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPLERENONE, EPLERENONE, BRINZOLAMIDE, BRINZOLAMIDE, MOMETASONE, MOMETASONE, FUROSEMIDE, ENALAPRIL, ENALAPRIL, APIXABAN, |
||||
| 128 | 26551019 |
US |
2 | |
Dyspnoea, Erythema, |
||||
| 129 | 26551045 |
EU |
6 | 1 |
Dystonia, Dyspnoea, Stridor, Accidental exposure to product by child, |
||||
OLANZAPINE, RISPERIDONE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 130 | 26551167 |
US |
2 | |
Acquired diaphragmatic eventration, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 131 | 26551188 |
US |
2 | |
Respiratory tract congestion, Cough, Nausea, Panic attack, Dyspnoea, Sleep disorder, |
||||
FLUTICASONE FUROATE, |
||||
| 132 | 26551250 |
GB |
50 | 1 |
Lower respiratory tract infection, Cough, Dyspnoea, |
||||
| 133 | 26551277 |
US |
29 | 2 |
Hepatic adenoma, Hepatic mass, Dyspnoea, Haemorrhage, |
||||
METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 134 | 26551286 |
US |
52 | 2 |
Intestinal obstruction, Volvulus, Dyspnoea, Dry eye, Injection site pain, |
||||
DUPILUMAB, |
||||
| 135 | 26551303 |
US |
53 | 2 |
Pneumonia, Dyspnoea, Nocturnal dyspnoea, Sleep disorder, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 136 | 26551305 |
IN |
23 | 1 |
Vena cava thrombosis, Atrial thrombosis, Endocarditis, Pulmonary embolism, Lung opacity, Pleural effusion, Dyspnoea, Lung consolidation, Rales, Candida infection, Pyrexia, Pain, Pain in extremity, Pallor, Pain of skin, Hepatosplenomegaly, Face oedema, Localised oedema, Oedema peripheral, Purpura, Dermatitis, Fatigue, Swelling face, Superior vena cava syndrome, Vasodilatation, Depression, |
||||
ELTROMBOPAG, ELTROMBOPAG OLAMINE, |
||||
| 137 | 26551314 |
US |
54 | 1 |
Infection, Chronic obstructive pulmonary disease, Dyspnoea, Cough, |
||||
DUPILUMAB, |
||||
| 138 | 26551315 |
US |
80 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
| 139 | 26551324 |
US |
41 | 1 |
Pneumonia, Cough, Dyspnoea, Pyrexia, Viral infection, |
||||
DUPILUMAB, |
||||
| 140 | 26551334 |
GB |
75 | |
Respiratory failure, Eyelid ptosis, Myocarditis-myositis-myasthenia gravis overlap syndrome, IIIrd nerve paralysis, Immunotoxicity, Dyspnoea, Diplopia, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 141 | 26551380 |
CA |
1 | |
Dyspnoea, Dizziness, Nausea, Respiratory syncytial virus infection, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 142 | 26551418 |
US |
64 | 2 |
Laryngitis, Headache, Anxiety, Painful respiration, Dyspnoea, Oxygen saturation decreased, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, FUROSEMIDE, SPIRONOLACTONE, EZETIMIBE, SERTRALINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 143 | 26551499 |
US |
22 | 1 |
Hereditary angioedema, Dysphagia, Pharyngitis, Throat irritation, Dyspnoea, Product dose omission issue, |
||||
GARADACIMAB, GARADACIMAB, |
||||
| 144 | 26551521 |
CA |
1 | |
Dyspnoea, General physical health deterioration, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 145 | 26551549 |
CA |
63 | 2 |
Discomfort, Chest pain, Tension, Eye movement disorder, Dyspnoea, Oxygen saturation decreased, Flushing, Unresponsive to stimuli, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), FAMOTIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 146 | 26551566 |
CO |
54 | 2 |
Neutropenia, Neutrophil count abnormal, White blood cell count abnormal, Pleural effusion, Haemoglobin abnormal, Dyspnoea, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, |
||||
| 147 | 26551658 |
CA |
62 | 2 |
Cyanosis, Dyspnoea, Chest discomfort, Livedo reticularis, Oxygen therapy, Erythema, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 148 | 26551744 |
CA |
20 | |
Presyncope, Suffocation feeling, Chest discomfort, Nausea, Dizziness, Dyspnoea, Refusal of treatment by patient, Patient uncooperative, Testicular pain, Aggression, Agitation, Weight increased, Pyrexia, Infusion related reaction, Off label use, Incorrect dose administered, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 149 | 26551764 |
US |
1 | |
Dyspnoea, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 150 | 26551816 |
US |
||
Throat irritation, Product quality issue, Dyspnoea, Infusion related reaction, |
||||
FOSAPREPITANT DIMEGLUMINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 151 | 26551852 |
US |
2 | |
Pneumonia, Oxygen saturation decreased, Oropharyngeal pain, Pulmonary pain, Dyspnoea, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 152 | 26551940 |
US |
2 | |
Dyspnoea, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 153 | 26552183 |
2 | ||
Rhinorrhoea, Epistaxis, Influenza, COVID-19, Pyrexia, Skin odour abnormal, Product odour abnormal, Dyspnoea, Nausea, |
||||
TERIPARATIDE, TERIPARATIDE, |
||||
| 154 | 26552245 |
GB |
70 | 1 |
Procedural anxiety, Abdominal discomfort, Death, Dyspnoea, |
||||
| 155 | 26552310 |
CA |
65 | 2 |
Pneumonia, Drug hypersensitivity, Oedema, Wheezing, Dyspnoea, Vomiting, Asthma, |
||||
FLUTICASONE PROPIONATE, AMINOPHYLLINE, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN, MONTELUKAST SODIUM, CIPROFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RITUXIMAB, RITUXIMAB, ROSUVASTATIN CALCIUM, RISEDRONATE SODIUM, TRAMADOL HYDROCHLORIDE, RISEDRONATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 156 | 26552314 |
EU |
2 | |
Fall, Dyspnoea, Fatigue, |
||||
AMIVANTAMAB-VMJW, |
||||
| 157 | 26552486 |
GB |
26 | 1 |
Dyspnoea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 158 | 26552561 |
52 | 1 | |
Anaphylactic shock, Dyspnoea, Muscle spasticity, Presyncope, Feeling hot, Paraesthesia, Dizziness, Blood pressure decreased, Loss of consciousness, |
||||
| 159 | 26552603 |
CN |
57 | 2 |
Malignant neoplasm progression, Ecchymosis, Dyspnoea, Arthralgia, Chest discomfort, Sensory disturbance, Antibody test positive, Lymphadenopathy, Feeling abnormal, |
||||
OSIMERTINIB, OSIMERTINIB, |
||||
| 160 | 26552621 |
US |
1 | |
Gait disturbance, Condition aggravated, Overdose, Dyspnoea, |
||||
| 161 | 26552628 |
US |
2 | |
Device delivery system issue, Dyspnoea, Device defective, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 162 | 26552686 |
US |
19 | 2 |
Dyspnoea, Flushing, Procedural anxiety, |
||||
FERRIC DERISOMALTOSE, |
||||
| 163 | 26552749 |
US |
1 | |
Pyrexia, Urine output decreased, Pruritus, Dyspnoea, Decreased appetite, Headache, Peripheral swelling, Joint swelling, Peripheral swelling, |
||||
| 164 | 26552776 |
US |
68 | 2 |
Pulmonary oedema, Chest discomfort, Dyspnoea, Drug ineffective, |
||||
ENSIFENTRINE, |
||||
| 165 | 26553081 |
US |
1 | |
Dyspnoea, Feeling abnormal, Dizziness, Drug interaction, |
||||
DEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESIN, |
||||
| 166 | 26553133 |
EU |
51 | 2 |
Pulmonary embolism, Cardiac arrest, Syncope, Dyspnoea, Malaise, Confusional state, |
||||
SEMAGLUTIDE, |
||||
| 167 | 26553198 |
US |
76 | 2 |
Dyspnoea, Flushing, Headache, Chest discomfort, |
||||
FLUTEMETAMOL F-18, ROSUVASTATIN, LOSARTAN, |
||||
| 168 | 26553260 |
US |
72 | 2 |
Respiratory syncytial virus infection, Fall, Craniofacial fracture, Haemorrhage, Malignant neoplasm progression, Pulmonary mass, Pancreatic cyst, Nail growth abnormal, Face injury, Post procedural complication, Dysphonia, Musculoskeletal stiffness, Back pain, Musculoskeletal pain, Pain in extremity, Vertigo, Chest discomfort, Weight increased, Fall, Asthma, Hot flush, Breast calcifications, Hair colour changes, Tongue discomfort, Scar, Increased tendency to bruise, Erythema, Dyspnoea, Cough, Fatigue, Diarrhoea, Decreased appetite, Nausea, Alopecia, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, GABAPENTIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, GUAIFENESIN, GUAIFENESIN, TEZEPELUMAB-EKKO, HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, ORNITHOGALUM UMBELLATUM, AND MALUS DOMESTICA FLOWER, CLEMATIS VITALBA FLOS, HELIANTHEMUM NUMMULARIUM FLOS, IMPATIENS GLANDULIFERA FLOS, ORNITHOGALUM UMBELLATUM FLOS, PRUNUS CERASIFERA FLOS, BIOTIN, IRON, ERGOCALCIFEROL, AZACITIDINE, |
||||
| 169 | 26553374 |
CA |
2 | |
Headache, Spinal stenosis, Dyspnoea, Asthenia, Dizziness, Cerebrospinal fluid leakage, |
||||
PREDNISONE, IPRATROPIUM BROMIDE, TIOTROPIUM BROMIDE INHALATION SPRAY, CICLESONIDE, ALBUTEROL SULFATE, |
||||
| 170 | 26553439 |
EU |
43 | 1 |
Schizophrenia, Personality disorder, Social anxiety disorder, Dyspnoea, Depression, Restlessness, Tremor, |
||||
ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE, OXAZEPAM, OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 171 | 26553559 |
US |
2 | |
Gastric ulcer, Dyspnoea, Anaemia, Product use in unapproved indication, |
||||
CEDAZURIDINE AND DECITABINE, |
||||
| 172 | 26553638 |
CA |
63 | 2 |
Dyspnoea, Fatigue, Oral pruritus, Arthralgia, Chills, Feeling cold, Joint swelling, Neck pain, Pain, Pain in jaw, Throat irritation, Dysphagia, Ear pruritus, Nasal pruritus, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIMENHYDRINATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE ACETATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 173 | 26553709 |
CA |
67 | 2 |
Lower respiratory tract infection, Neuropathy peripheral, Paraesthesia, Headache, Memory impairment, Dizziness, Arthralgia, Dyspnoea, Urinary tract infection, Dysuria, Abdominal discomfort, Headache, Insomnia, Muscle twitching, Asthenia, |
||||
RIBOCICLIB, |
||||
| 174 | 26553714 |
GB |
66 | 1 |
Blood pressure increased, Chest discomfort, Hypertension, Asthma, Dyspnoea, |
||||
DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, |
||||
| 175 | 26553856 |
US |
2 | |
Tachycardia, Dyspnoea, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE, |
||||
| 176 | 26553862 |
72 | ||
Dyspnoea, Rash, Tracheal obstruction, Therapy interrupted, Product dispensing issue, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 177 | 26553886 |
US |
1 | |
Immunodeficiency, Dyspnoea, Bronchospasm, |
||||
RAVULIZUMAB, |
||||
| 178 | 26553888 |
BR |
63 | 2 |
Asthmatic crisis, Thrombosis, Arrhythmia, Cough, Dyspnoea, Pollakiuria, Diarrhoea, Device delivery system issue, Product quality issue, Product dose omission issue, Product availability issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 179 | 26553925 |
GB |
2 | |
Dyspnoea, Palpitations, Hypertension, Feeling cold, |
||||
SEMAGLUTIDE, |
||||
| 180 | 26554013 |
US |
1 | |
Dyspnoea, Incorrect product administration duration, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
ENSIFENTRINE, ENSIFENTRINE, PATIROMER, |
||||
| 181 | 26554040 |
US |
1 | |
Dyspnoea, Muscle strain, Product dose omission issue, Intentional underdose, Insurance issue, |
||||
ENSIFENTRINE, ENSIFENTRINE, |
||||
| 182 | 26554043 |
US |
1 | |
Dyspnoea, |
||||
ENSIFENTRINE, |
||||
| 183 | 26554044 |
US |
58 | 1 |
Bronchospasm, Dyspnoea, Drug hypersensitivity, |
||||
ENSIFENTRINE, |
||||
| 184 | 26554047 |
US |
1 | |
Productive cough, Dyspnoea, Drug ineffective, |
||||
ENSIFENTRINE, |
||||
| 185 | 26554067 |
US |
2 | |
Dyspnoea, Product dose omission issue, |
||||
ENSIFENTRINE, |
||||
| 186 | 26554070 |
US |
1 | |
Dyspnoea, Pain in extremity, Diarrhoea, Drug ineffective, |
||||
ENSIFENTRINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, IRON, |
||||
| 187 | 26554072 |
US |
||
Dyspnoea, |
||||
ENSIFENTRINE, |
||||
| 188 | 26554087 |
US |
81 | 1 |
Peripheral swelling, Dyspnoea, Dyspnoea exertional, Condition aggravated, |
||||
ENSIFENTRINE, ENSIFENTRINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FUROSEMIDE, |
||||
| 189 | 26554100 |
US |
2 | |
Dyspnoea, |
||||
ENSIFENTRINE, |
||||
| 190 | 26554121 |
US |
1 | |
Abdominal discomfort, Dyspnoea, Drug ineffective, |
||||
ENSIFENTRINE, |
||||
| 191 | 26554132 |
US |
1 | |
Dyspnoea, Blood glucose decreased, |
||||
ENSIFENTRINE, |
||||
| 192 | 26554133 |
US |
77 | 2 |
Malaise, Dyspnoea, Product dose omission issue, Product solubility abnormal, |
||||
ENSIFENTRINE, ENSIFENTRINE, |
||||
| 193 | 26554136 |
US |
63 | 1 |
Cough, Dyspnoea, Chest discomfort, Back pain, Depressed mood, |
||||
ENSIFENTRINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 194 | 26554141 |
2 | ||
Anaphylactic reaction, Cough, Dyspnoea, Wheezing, Erythema, |
||||
IOPROMIDE, |
||||
| 195 | 26554143 |
US |
2 | |
Dyspnoea, |
||||
ENSIFENTRINE, |
||||
| 196 | 26554147 |
US |
1 | |
Dyspnoea, |
||||
ENSIFENTRINE, |
||||
| 197 | 26554154 |
EU |
47 | 2 |
Influenza, Neutropenia, Pulmonary embolism, Dyspnoea, Pneumonia, |
||||
TRASTUZUMAB, PERTUZUMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 198 | 26554217 |
US |
6 | 2 |
Death, Dyspnoea, Neoplasm progression, Acute respiratory failure, Metastases to meninges, Dysphagia, Seizure, |
||||
DORDAVIPRONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FAMOTIDINE, SIMVASTATIN, LEVETIRACETAM, LEVETIRACETAM, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, SENNOSIDES, SENNA LEAF, SENNA, GLYCOPYRROLATE, MORPHINE SULFATE, DEXMEDETOMIDINE HYDROCHLORIDE, SIMVASTATIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 199 | 26554265 |
US |
||
Dyspnoea, Chest discomfort, |
||||
TIRZEPATIDE, |
||||
| 200 | 26554273 |
JP |
84 | 1 |
Dyspnoea, Diarrhoea, Pruritus, Condition aggravated, Peripheral coldness, Peripheral coldness, Abdominal distension, Chest discomfort, Decreased appetite, Feeding disorder, Abdominal pain upper, Taste disorder, Decreased appetite, Visual impairment, Dizziness, Nausea, Ligament sprain, Fall, Arthralgia, Bedridden, Dyspnoea, Dry skin, Vision blurred, |
||||
NINTEDANIB, NINTEDANIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28